ADVERTISEMENT

Artificial Intelligence

MHRA Backs Global AI Framework For Pharmacovigilance Over UK-Specific Guidance

The UK’s medicines regulator wants to ensure that guidance on the use of artificial intelligence in pharmacovigilance processes remains fit for the future.

Opportunities For AI In Pricing, Reimbursement Abound, But Use Remains Rare

A July white paper from Lifescience Dynamics explores the potential ways AI could see usage in pricing, reimbursement and market access for biopharma companies.

BioBytes: Israeli-US Startup Introduces Platform For Accelerated Clinical Data Analysis

A new AI-based platform is designed to condense months of clinical data analysis into minutes by translating plain language data queries into epidemiologically valid research requests.

Generic Drugs And AI: Maximum Daily Dose Tool Could Help US FDA Be ‘At The Forefront’

The FDA is testing a new artificial intelligence tool to help generic drug developers automate maximum daily dose calculations.

Infographic: How Big Pharma Is Scaling Beyond Pilot AI Projects

Pharma leaders are shifting from AI pilots to enterprise-scale deployment, favoring external partnerships for efficiency gains while maintaining tight control over sensitive clinical data.

New South Korea Health Minister Vows ‘People-Centric’ Medical System

In line with new President Lee’s campaign pledges, South Korea's newly confirmed health minister is expected to tackle key issues including a prolonged doctors' conflict, essential drug supplies and R&D support for the industry.

Korean Biopharma Catching Up On AI, But What Are The Challenges?

While South Korea's biopharma sector has made progress in its digital transformation, including the adoption of AI technologies, a recent report has identified multiple remaining challenges.

Digital Health Roundup: Autonomous Robots, Medtronic’s Surgeon School, Sleep & FDA Rules

In this week's Digital Health Roundup, Medtech Insight's team discusses progress on autonomous surgery, Medtronic's new partnership with IRCAD, FDA cybersecurity news, and C-suite interviews with OpenWater, Flow Neuroscience and EnsoData.

AI In Biologics Discovery: The Expensive Bet On Unproven Promise

Despite limited evidence of commercial impact, pharmaceutical companies are making massive strategic investments in AI biologics platforms. The question isn't whether the technology shows promise; it's whether that promise can translate to measurable business results.

BioBytes: AI-Related Deals In Q2 ‘25

When it came to AI-related deals, the second quarter of 2025 was characterized by mostly modest financings.

AI Agents Set To Reshape Biopharma’s Workforce And Operations

While biopharma companies experiment with genAI, agentic AI is rapidly shifting the work paradigm towards one of autonomous digital workers that can handle entire process flows.

EU Medtech Outlook: The View From MedTech Europe Experts

MedTech Forum 2025 was less MDR-focused than in previous years, as macro issues and exogenous threats were forced further into the center of medtech business thinking.